Aethlon Med

AEMD NASDAQ
0.3159
-0.0141
-4.27%
盘后: 0.3123 +0.0073 +2.39% 16:00 07/15 EDT
开盘
0.3250
昨收
0.3300
最高
0.3380
最低
0.3000
成交量
43.33万
成交均量(3M)
27.01万
52周最高
1.740
52周最低
0.3000
换手率
2.27%
市值
582.66万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Aethlon Med AEMD股票价格,Aethlon Med股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
展开 >

最近浏览

名称
价格
涨跌幅